Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 4,533,000 | 3,302,000 | 1,250,000 |
| Marketable Securities | 0 | N/A | 1,665,000 | 1,461,000 | 1,243,000 |
| Receivables | 0 | N/A | 1,941,000 | 1,766,000 | 1,666,000 |
| Inventories | 0 | N/A | 1,299,000 | 1,493,000 | 1,178,000 |
| Income taxes - deferred | N/A | N/A | 500,000 | 614,000 | 278,000 |
| TOTAL | $0 | $N/A | $10,073,000 | $8,753,000 | $5,704,000 |
| Non-Current Assets | |||||
| PPE Net | 0 | N/A | 5,404,000 | 4,986,000 | 4,173,000 |
| Investments And Advances | 0 | 0 | 3,347,000 | 2,090,000 | 1,832,000 |
| Intangibles | 0 | 0 | 2,598,000 | 2,745,000 | 1,791,000 |
| Other Non-Current Assets | 0 | 0 | 365,000 | 366,000 | 1,342,000 |
| TOTAL | $N/A | $N/A | $11,714,000 | $10,187,000 | $9,138,000 |
| Total Assets | $0 | $N/A | $21,787,000 | $18,940,000 | $14,842,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 228,000 | 420,000 | 346,000 |
| Accrued Expenses | 0 | N/A | N/A | 776,000 | N/A |
| TOTAL | $0 | $N/A | $3,095,000 | $3,918,000 | $2,010,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | 2,329,000 | 2,402,000 | 2,204,000 |
| Deferred Revenues | N/A | N/A | 88,000 | 73,000 | 62,000 |
| Other Non-Current Liabilities | 530 | 0 | 248,000 | 297,000 | 951,000 |
| TOTAL | $N/A | $N/A | $3,021,000 | $3,117,000 | $3,354,000 |
| Total Liabilities | $0 | $N/A | $6,116,000 | $7,035,000 | $5,364,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 1,053,414 | 1,053,124 | 1,053,186 |
| Common Shares | 0 | N/A | 21,000 | 21,000 | 21,000 |
| Retained earnings | 0 | N/A | 3,482,000 | 992,000 | -838,000 |
| Other shareholders' equity | 0 | 0 | 124,000 | 197,000 | 204,000 |
| TOTAL | $0 | $N/A | $15,671,000 | $11,905,000 | $9,478,000 |
| Total Liabilities And Equity | $0 | $0 | $21,787,000 | $18,940,000 | $14,842,000 |